Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1855 1
1859 3
1860 2
1867 1
1875 1
1876 2
1919 1
1923 1
1931 1
1932 1
1936 1
1938 1
1947 3
1948 4
1949 3
1950 7
1952 5
1953 4
1954 7
1955 7
1956 7
1957 3
1958 2
1959 7
1960 4
1961 2
1962 11
1963 14
1964 14
1965 17
1966 11
1967 10
1968 13
1969 13
1970 15
1971 16
1972 13
1973 17
1974 9
1975 12
1976 8
1977 8
1978 13
1979 21
1980 16
1981 21
1982 28
1983 25
1984 12
1985 23
1986 21
1987 39
1988 34
1989 33
1990 54
1991 53
1992 52
1993 45
1994 53
1995 44
1996 37
1997 37
1998 33
1999 35
2000 33
2001 24
2002 27
2003 41
2004 34
2005 45
2006 51
2007 61
2008 69
2009 64
2010 69
2011 94
2012 96
2013 98
2014 85
2015 92
2016 84
2017 102
2018 97
2019 77
2020 94
2021 81
2022 73
2023 74
2024 71
2025 62

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,587 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME. Geisler AN, et al. Among authors: phillips gs. J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23. J Am Acad Dermatol. 2020. PMID: 32454097 Free PMC article. Review.
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT).
Saccà F, Barnett C, Vu T, Peric S, Phillips GA, Zhao S, Qi CZ, Gelinas D, Chiroli S, Verschuuren JJGM. Saccà F, et al. Among authors: phillips ga. J Neurol. 2023 Apr;270(4):2096-2105. doi: 10.1007/s00415-022-11517-w. Epub 2023 Jan 4. J Neurol. 2023. PMID: 36598575 Free PMC article. Clinical Trial.
Whither the protein landscape?
Carter CW Jr, Phillips GN Jr. Carter CW Jr, et al. Among authors: phillips gn jr. Struct Dyn. 2025 Feb 5;12(1):010401. doi: 10.1063/4.0000291. eCollection 2025 Jan. Struct Dyn. 2025. PMID: 39917080 Free PMC article. No abstract available.
Treatment Outcomes of Immune-Related Cutaneous Adverse Events.
Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, Chan D, Dusza S, Motzer RJ, Rosenberg JE, Callahan MK, Chapman PB, Geskin L, Lopez AT, Reed VA, Fabbrocini G, Annunziata MC, Kukoyi O, Pabani A, Yang CH, Chung WH, Markova A, Lacouture ME. Phillips GS, et al. J Clin Oncol. 2019 Oct 20;37(30):2746-2758. doi: 10.1200/JCO.18.02141. Epub 2019 Jun 19. J Clin Oncol. 2019. PMID: 31216228 Free PMC article.
PLASTA-BAPRAS-SAC simulation training symposium.
Joji N, Batten G, Phillips G, Mikhail M, Reissis D, Mohanna PN. Joji N, et al. Among authors: phillips g. J Plast Reconstr Aesthet Surg. 2023 Sep;84:132-133. doi: 10.1016/j.bjps.2023.05.057. Epub 2023 Jun 1. J Plast Reconstr Aesthet Surg. 2023. PMID: 37329746 No abstract available.
2,587 results